Tag Archives: Bloomberg

Antitrust Trial for Anthem, Cigna Begins; what to expect with Republicans in charge

Anthem Inc. (Indianapolis IN), Cigna Corp. (Bloomfield CT) and the U.S. government on Monday (November 21, 2016) offered a federal judge very different views of the impact their proposed $48… Read more »

Obamacare startup Oscar racks up $45-million 3Q Loss; Trump’s healthcare agenda meddling with in-law’s $2.7-billion bet

Oscar Insurance Corp. (New York City), the Silicon Valley-backed healthcare startup, continued to lose tens of millions of dollars in the third quarter as the company exits some markets and works… Read more »

Novartis slowly, quietly imploding; will Alcon, Amneal moves halt spiral?

Renewed whispers from Swiss drugmaker Novartis AG (Basel) that it could divest its struggling Alcon eyecare business reflect the latest step in dismantling former leader Dan Vasella’s vision of building… Read more »

Valeant stock plunges anew on dismal 3Q results; behold another pharma Sisyphus

After an already noisy year, Valeant Pharmaceuticals International Inc. (Laval Québec) once again took investors off guard–this time, on Election Day–as new management cut the annual profit forecast to well… Read more »

Trump win sends pharma stocks up, while hospitals plunge; fate of Obamacare far from clear

Pharmaceutical stocks and bonds were among the day’s biggest winners Wednesday (November 9, 2016) as the sweeping Republican victory in US elections eased concern that price controls might be imposed… Read more »

Anthem misses Street’s 3Q street profit forecast; threat to leave Obamacare a much bigger worry

Health insurance giant Anthem Inc. (Indianapolis IN) said it expects its individual business under the Affordable Care Act to return to “slight profitability” in 2017, but won’t commit to providing such coverage… Read more »

Pharma stocks dive on price-fixing probes; better days for healthcare sector uncertain no matter who’s in the White House

The generic drug industry was jolted last week as shares of many major companies tumbled after a news report said that a federal inquiry into drug price-fixing was wider than… Read more »

Ariad Pharma’s Slide Continues as Bernie Sanders Seeks Data on Leukemia Drug; Recent Drug Price Hikes Put Company on Familiar Hot Seat

Ariad Pharmaceuticals Inc. (Cambridge MA) continued to plummet Thursday (October 20, 2016) after Vermont Sen. Bernie Sanders and Maryland Rep. Elijah Cummings sent a letter to the company, demanding more information about… Read more »

Healthcare Stocks Tumble as Clinton’s Lead Widens; Are the Jitters Justified or Do Opportunities Abound?

Democratic presidential nominee Hillary Clinton has been named the culprit for beating down biotech stocks just for squealing about high drug prices on Twitter. Imagine the ever-increasing likelihood of her becoming the… Read more »